MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/epi.12492

Медицинская библиотека · Epilepsia · 2014

First clinical experiences with perampanel--the Kork experience in 74 patients.

Steinhoff Bernhard J, Bacher Matthias, Bast Thomas, Kornmeier Reinhold, Kurth Christoph, Scholly Julia, Staack Anke M, Wisniewski Ilona

СтатьяПеревод в очереди

Аннотация

Perampanel (PER) has been approved for adjunctive treatment of partial-onset seizures in patients age 12 years and older. In Germany, PER was licensed and marketed in September of 2012. At our tertiary referral epilepsy center, a couple of difficult-to-treat patients were awaiting this introduction of PER; therefore, we were able to initiate treatment in many patients within a short period of time. For this report we collected and analyzed the data of the first patients who had been started on add-on PER between September and December of 2012, so that we were able to evaluate at least 6 months of treatment when we made this analysis. At cutoff in June of 2013, 74 patients could be analyzed. Mean age was 38.4 years (range 15-71 years). PER doses ranged from 4 to 14 mg (mean 8.8 mg). All patients took PER once daily at bedtime. Seventy-one patients had focal epileptic seizures; the remaining four patients had Lennox-Gastaut syndrome. Considering the last 3 months of observation compared with baseline, 34 patients (46%) were responders with a reduction of seizure frequency of at least 50%. Ten patients of these (14% of all) were seizure-free. Adverse events were reported in 40 patients (54%). Leading side effects were somnolence (n = 31, 42%) and dizziness (n = 13, 18%), followed by ataxia, irritability, falls, cognitive slowing, and depression in single cases. Six-month retention rate was 70%. Our first clinical experiences with add-on PER in a highly selected group of difficult-to-treat epilepsies are promising.

Для цитирования: Steinhoff Bernhard J, Bacher Matthias, Bast Thomas, Kornmeier Reinhold, Kurth Christoph, Scholly Julia, Staack Anke M, Wisniewski Ilona. First clinical experiences with perampanel--the Kork experience in 74 patients.. Epilepsia. 2014. DOI: 10.1111/epi.12492.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.